Tango Therapeutics, Inc. TNGX
24.30 USD +1.56 (+6.86%)
At closeNov 11, 2026, 4:01 AM EST
23.05 -1.25 -5.14%
Pre-market · Nov 11, 4:01 AM ET
22.38 Day range 24.65
7.49 52-week range 34.39
- YTD
- +174.27%
- 1 year
- +206.43%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 62.38M | 42.07M | 36.53M | 24.86M | 37.04M | |
| 62.38M | 42.07M | 36.53M | 24.86M | 37.04M | |
| -111.29M | -145.59M | -114.17M | -111.07M | -58.19M | |
| -101.59M | -130.30M | -101.74M | -108.18M | -58.23M | |
| -0.87 | -1.19 | -1.08 | -1.23 | -0.94 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 112.71M | 69.53M | 67.24M | 60.53M | 143.31M | |
| 398.69M | 316.49M | 402.57M | 436.47M | 500.15M | |
| 52.51M | 116.97M | 149.46M | 186.99M | 155.41M | |
| 33.57M | 36.49M | 38.92M | 41.13M | 1.50M | |
| 346.18M | 199.52M | 253.11M | 249.48M | 344.75M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -138.89M | -131.50M | -117.98M | -109.08M | -59.53M | |
| -40.87M | 86.13M | 41.43M | 26.40M | -183.43M | |
| 222.50M | 47.66M | 82.41M | 1.61M | 357.32M | |
| -1.05M | -754.00K | -1.53M | -7.69M | -1.84M | |
| 42.75M | 2.29M | 5.85M | -81.07M | 114.36M |